S&P futures are up 0.1% in Monday pre-market trading following a week where the S&P 500 lost over 2% and the Nasdaq shed more than 3%, erasing post-election gains. European and Asian equities are mostly lower, with China leading declines. Treasuries are little changed to weaker, with the curve steepening. The Dollar index is flat, […]
ETFsector.com Daily Trading Outlook, November 18, 2024 Read More »
S&P futures are down 0.5% in Monday premarket trading, giving back some of Friday’s gains. This comes after stronger-than-expected nonfarm payrolls boosted hopes of a soft landing, but also tempered expectations for a 50bp Fed rate cut in November, shifting focus to a 25bp move. European markets are mostly lower after a strong Asian session.
ETFsector.com Daily Trading Outlook, October 7th, 2024 Read More »
S&P futures are down 0.3% in Thursday morning trading, following a mixed close for US equities on Wednesday. Semiconductors and China tech outperformed, while apparel, retail, autos, builders, and food/beverage lagged. TSLA-US led declines among the Mag 7 stocks. Treasuries weakened, and the dollar index rose 0.2%, with sterling under pressure due to dovish BoE
ETFsector.com Daily Trading Outlook, October 3rd, 2024 Read More »
In the second quarter, Dark Forest Capital Management LP acquired a new stake in CVS Health Co. as disclosed in their recent filing with the Securities and Exchange Commission.
The article examines the top 10 mid-cap healthcare stocks currently worth investing in. It discusses growth projections, challenges, and technological innovations in the global healthcare market.
Top 10 healthcare stocks with a mid-cap size to consider investing in. Read More »
Flu and COVID-19 vaccines have been recently made available at CVS Pharmacy and MinuteClinic.
CVS investors are being given the chance to take the lead in a securities fraud lawsuit against CVS Health Corporation.
Voisard Asset Management Group Inc. purchased additional shares of CVS Health Co. during the fourth quarter, as indicated in the company’s latest 13F filing.
Pomerantz Law Firm is investigating claims on behalf of investors of CVS Health Corporation.
Pomerantz LLP is conducting an investigation on behalf of investors of CVS Health Corporation (CVS) regarding possible claims. Investors of the company are being advised to take note of the investigation.
Stay updated with the latests analysis and insights fromm etfsector.com